Top 3 Health Care Stocks Poised for Big Gains in Q2

Some of the most oversold health care stocks could be setting up for a rebound this quarter. When a stock’s Relative Strength Index (RSI) dips near or below 30, it may signal that the stock is oversold—and potentially undervalued.

Below are three health care stocks with RSI levels near or under 30, suggesting a potential turnaround could be ahead.


1. Edgewise Therapeutics Inc (NASDAQ: EWTX)

  • RSI Value: 27.5

  • Current Price: $12.50 (+8.8% on Wednesday)

  • 52-Week Low: $10.60

  • Momentum Score: 15.43

📢 On April 2, Edgewise Therapeutics priced a public offering of 9.94 million shares at $20.13 each, aiming to raise $200 million. The offering closed April 3.
📉 The stock has dropped roughly 55% over the past month, signaling potential for a rebound after hitting a new low.


2. Genfit SA (NASDAQ: GNFT)

  • RSI Value: 29.3

  • Current Price: $2.64 (-21.4% on Wednesday)

  • 52-Week Low: $2.55

💬 On February 7, HC Wainwright analyst Ed Arce reaffirmed a Buy rating with a $13 price target.
📉 Genfit stock has plummeted 27% in the last 5 days, pushing it deep into oversold territory.


3. CAMP4 Therapeutics Corp (NASDAQ: CAMP)

  • RSI Value: 23.1

  • Current Price: $2.14 (-7.4% on Wednesday)

  • 52-Week Low: $0.39

🧬 CEO Josh Mandel-Brehm highlighted major wins in 2024, including IPO completion, regulatory milestones, and Phase 1 clinical progress.
📉 Despite these positives, CAMP4 shares have slid 49% over the past month, making it one of the most oversold stocks on this list.


🔍 Why RSI Matters

The RSI helps traders spot short-term momentum shifts. A reading under 30 suggests a stock is oversold and could bounce back—especially when paired with positive fundamentals or news.


🔍 Further Reading from Finance Monthly

Follow Finance Monthly
Just for you
Andrew Palmer

Share this article

Patner Ad